Available studies have shown that RTN-4A and its receptor NgR1 may contribute to the pathogenesis of MS by inhibiting axonal and myelin regeneration and regulating the activation of M1/M2 macrophage via MAPK, ER stress, or transcriptional regulators Yap. The gene discussed is RTN4R; the disease is myeloid sarcoma.